Dr. Vasco Marques, MD
What this data tells you about Dr. Marques
Dr. Vasco Marques is an interventional cardiology in Tampa, FL, with 19 years in practice. Based on federal Medicare data, Dr. Marques performed 3,042 Medicare services across 1,930 unique beneficiaries.
Between the years covered by Open Payments, Dr. Marques received a total of $62,083 from 63 pharmaceutical and/or device companies across 548 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Marques is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) | 529 | $91 | $215 |
| Office visit, established patient (20-29 min) | 523 | $63 | $146 |
| Regadenoson injection (Lexiscan) for heart stress test | 404 | $48 | $190 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 252 | $90 | $236 |
| Echocardiogram, transthoracic | 170 | $146 | $449 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 148 | $27 | $72 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 136 | $49 | $152 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 126 | $333 | $954 |
| Remote pacemaker/defibrillator monitoring, 90 days | 107 | $16 | $51 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 90 | $20 | $54 |
| Remote pacemaker monitoring, 90 days | 65 | $21 | $69 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 58 | $19 | $55 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 53 | $134 | $387 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 43 | $27 | $138 |
| Evaluation of implantable heart and blood vessel monitoring system | 42 | $13 | $44 |
| Programming of dual lead pacemaker system | 40 | $22 | $78 |
| Heart rhythm recording of continous external ekg over 8-15 days | 37 | $9 | $32 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 37 | $20 | $59 |
| New patient office visit (30-44 min) | 30 | $81 | $218 |
| Ultrasound of both sides of head and neck blood flow | 29 | $149 | $398 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 25 | $9 | $32 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 25 | $19 | $54 |
| Ultrasound of leg arteries or artery grafts | 25 | $179 | $508 |
| Ultrasound study of one arm or leg veins with compression and maneuvers | 19 | $93 | $236 |
| Chemical destruction of first incompetent vein of arm or leg using imaging guidance | 16 | $1,267 | $4,149 |
| Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | 13 | $140 | $376 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (81%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in interventional cardiology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 8% for interventional cardiology in FL.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Marques is a cardiac & remote specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 8%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Marques experienced with office visit, established patient (30-39 min)?
Does Dr. Marques receive payments from pharmaceutical companies?
How do Dr. Marques's costs compare to other interventional cardiologys in Tampa?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology